ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Turn Therapeutics (Direct Listing)
3.51
-0.0750
-2.09%
盤後:
3.51
0.0000
0.00%
16:25 EST
成交量:
9,835.00
成交額:
3.49萬
市值:
1.03億
市盈率:
-27.22
高:
3.62
開:
3.59
低:
3.51
收:
3.59
52周最高:
26.50
52周最低:
2.57
股本:
2,944.52萬
流通股本:
1,786.88萬
量比:
0.76
換手率:
0.06%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.1289
每股收益(LYR):
-0.0659
淨資產收益率:
-2324.83%
總資產收益率:
-78.67%
市淨率:
205.06
市盈率(LYR):
-53.28
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Turn Therapeutics 任命資本市場資深專家 Andrew Scott 為企業傳播副總裁
美股速递
·
2025/11/05
Turn Therapeutics與領先的醫用外科產品製造和分銷商Medline簽署全球供應、開發和許可協議
美股速递
·
2025/10/30
Turn Therapeutics發布股東更新,強調在臨牀和戰略里程碑上的持續進展
美股速递
·
2025/10/22
Turn Therapeutics任命Arthur Golden為董事會成員
投资观察
·
2025/10/15
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TTRX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TTRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTRX\",,,,,undefined,":{"symbol":"TTRX","market":"US","secType":"STK","nameCN":"Turn Therapeutics (Direct Listing)","latestPrice":3.51,"timestamp":1771016400000,"preClose":3.585,"halted":0,"volume":9835,"hourTrading":{"tag":"盘后","latestPrice":3.51,"preClose":3.51,"latestTime":"16:25 EST","volume":29,"amount":105.06,"timestamp":1771017904045,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02092050209205026,"floatShares":17868800,"shares":29445200,"eps":-0.12892704,"marketStatus":"已收盤","change":-0.075,"latestTime":"02-13 16:00:00 EST","open":3.59,"high":3.62,"low":3.51,"amount":34916.890954,"amplitude":0.030683,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.12892704,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":5,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":3.585,"preHourTrading":{"tag":"盘前","latestPrice":3.58,"preClose":3.64,"latestTime":"08:00 EST","volume":22,"amount":78.76,"timestamp":1770987604226,"change":-0.06,"changeRate":-0.016484,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.51,"preClose":3.51,"latestTime":"16:25 EST","volume":29,"amount":105.06,"timestamp":1771017904045,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.758546},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTRX\",,,,,undefined,":{"symbol":"TTRX","floatShares":17868800,"roa":"-78.67%","roe":"-2324.83%","lyrEps":-0.065873,"volumeRatio":0.758546,"shares":29445200,"dividePrice":0,"high":3.62,"amplitude":0.030683,"preClose":3.585,"low":3.51,"week52Low":2.5701,"pbRate":"205.06","week52High":26.5,"institutionHeld":0,"latestPrice":3.51,"eps":-0.12892704,"divideRate":0,"volume":9835,"delay":0,"ttmEps":-0.12892704,"open":3.59,"prevYearClose":3.94,"prevWeekClose":3.85,"prevMonthClose":4.12,"prevQuarterClose":3.94,"fiveDayClose":3.85,"twentyDayClose":4.82,"sixtyDayClose":3.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TTRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TTRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TTRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1768971600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TTRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TTRX","date":"2026-02-12","current":-27.2247,"percent":0.697674,"low":-100.764104,"twenty":-48.36677,"median":-35.368844,"eighty":-25.880883,"high":-21.019642,"avg":-38.163774,"sd":14.972733,"marketCap":106297110},"quantilePoints":[{"date":"2025-10-10","current":-100.764104,"twenty":-95.944951,"median":-88.716222,"eighty":-81.487493,"marketCap":257809999},{"date":"2025-10-17","current":-61.772777,"twenty":-80.611283,"median":-71.301556,"eighty":-62.49565,"marketCap":158048738},{"date":"2025-10-24","current":-54.215469,"twenty":-75.594983,"median":-58.815569,"eighty":-54.127848,"marketCap":138712988},{"date":"2025-10-31","current":-57.391729,"twenty":-70.118673,"median":-57.391729,"eighty":-54.25928,"marketCap":146839608},{"date":"2025-11-07","current":-46.548635,"twenty":-64.664269,"median":-55.529784,"eighty":-49.111548,"marketCap":119097010},{"date":"2025-11-14","current":-44.796216,"twenty":-60.918473,"median":-54.215469,"eighty":-46.701972,"marketCap":114613358},{"date":"2025-11-21","current":-21.019642,"twenty":-57.501255,"median":-52.517813,"eighty":-44.182869,"marketCap":79796445},{"date":"2025-11-28","current":-27.302265,"twenty":-57.501255,"median":-48.301054,"eighty":-27.302265,"marketCap":103647044},{"date":"2025-12-05","current":-32.964383,"twenty":-57.391729,"median":-47.315318,"eighty":-27.302265,"marketCap":125142027},{"date":"2025-12-12","current":-24.897804,"twenty":-55.858362,"median":-45.508136,"eighty":-26.138816,"marketCap":94519037},{"date":"2025-12-19","current":-23.268976,"twenty":-55.63931,"median":-44.029532,"eighty":-25.595874,"marketCap":88335549},{"date":"2025-12-26","current":-23.036286,"twenty":-55.464068,"median":-42.496165,"eighty":-24.137684,"marketCap":87452193},{"date":"2026-01-02","current":-30.559922,"twenty":-54.828816,"median":-32.964383,"eighty":-24.075634,"marketCap":116014021},{"date":"2026-01-09","current":-36.066913,"twenty":-54.30309,"median":-35.136154,"eighty":-24.292811,"marketCap":136920100},{"date":"2026-01-16","current":-37.385488,"twenty":-54.149753,"median":-35.834223,"eighty":-24.680627,"marketCap":141925782},{"date":"2026-01-23","current":-36.687419,"twenty":-53.711649,"median":-35.834223,"eighty":-25.083956,"marketCap":139275715},{"date":"2026-01-30","current":-33.740015,"twenty":-52.638292,"median":-35.911787,"eighty":-25.45626,"marketCap":128086546},{"date":"2026-02-06","current":-28.698404,"twenty":-50.513483,"median":-35.446407,"eighty":-25.69184,"marketCap":108947177},{"date":"2026-02-12","current":-28.000335,"twenty":-48.36677,"median":-35.368844,"eighty":-25.880883,"marketCap":106297110}],"updateTime":1771033709842},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TTRX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1112036493","title":"Turn Therapeutics 任命資本市場資深專家 Andrew Scott 為企業傳播副總裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1112036493","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112036493?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 06:09","pubTimestamp":1762294167,"startTime":"0","endTime":"0","summary":"Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1103328553","title":"Turn Therapeutics與領先的醫用外科產品製造和分銷商Medline簽署全球供應、開發和許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1103328553","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103328553?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 19:31","pubTimestamp":1761823868,"startTime":"0","endTime":"0","summary":"Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1148388176","title":"Turn Therapeutics發布股東更新,強調在臨牀和戰略里程碑上的持續進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1148388176","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148388176?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 20:03","pubTimestamp":1761134630,"startTime":"0","endTime":"0","summary":"Turn Therapeutics发布股东更新,强调在临床和战略里程碑上的持续进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1150228317","title":"Turn Therapeutics任命Arthur Golden為董事會成員","url":"https://stock-news.laohu8.com/highlight/detail?id=1150228317","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150228317?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 00:09","pubTimestamp":1760458140,"startTime":"0","endTime":"0","summary":"加利福尼亚州韦斯特莱克村,2025年10月14日——Turn Therapeutics是一家处于临床阶段的生物技术公司,专注于开发下一代皮肤病学、创伤护理和抗感染疗法。公司宣布任命Arthur Golden为董事会成员,他是一位资深企业董事会顾问,在并购交易、股东关系、合规和治理方面拥有丰富经验。他拥有数十年的企业董事经验,最近担任Emerson Electric董事24年,并担任企业治理和财务委员会主席,同时是执行委员会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TTRX","LENZ","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TTRX\",params:#limit:6,delay:false,,,undefined,":[]}}